HACARUS to Exhibit its Latest Medical & Life Science AI at healthTECH Japan 2023

HACARUS To Exhibit Its Latest Medical & Life Science AI At HealthTECH Japan 2023

HACARUS will host live demonstrations and seminars during the 3 day expo

September 19th, 2023, Kyoto, Japan – HACARUS, on a mission to bring the next generation of instruments to every industry, today announced that it will exhibit at healthTECH JAPAN, to be held at Pacifico Yokohama from October 11th (Wed) to 13th (Fri) 2023.

At booth H-15, HACARUS MD, an AI platform that supports medical diagnosis, HACARUS DD, which streamlines image analysis in the drug discovery process through AI and HACARUS Check, which automates visual inspection in manufacturing processes will be exhibited. HACARUS will also be speaking at two seminars on the healthTECH Stage on October 11th and October 12th about its medical AI platform as well as HACARUS MD for Colposcopy.

Concurrently, at Pacifico Yokohama, BioJapan, the world’s oldest biotechnology exhibition (since 1986), and Regenerative Medicine JAPAN, which aims to accelerate and industrialize research and development in the field of regenerative medicine, including iPS cells will be held. The trade show also allows for business matching and partnering among industry, academia, start-ups and government, both from Japan and abroad.

Exhibition overview

  • Name: healthTECH JAPAN
  • ​Period: October 11th (Wednesday) to 13th (Friday), 2023 10:00-17:00
  • Venue: Pacifico Yokohama
  • Visitor information: https://jcd-expo.jp/en/

Exhibit Overview

HACARUS MD, Diagnosis Support AI Platform

HACARUS MD is a diagnostic support AI platform that supports healthcare professionals.
With HACARUS’s proprietary AI technology, it is possible to build highly interpretable AI without using big data. Our mission is to provide accurate and prompt diagnostic support in all medical settings.

HACARUS DD, Drug Discovery Support AI platform

Our AI platform supports drug discovery researchers by streamlining image analysis. HACARUS’s original AI technology builds highly interpretable AI without using big data. By combining the knowledge of drug discovery researchers with AI, we will contribute to the realization of a more efficient and rapid drug discovery process.

HACARUS CHECK, Enabling automation and streamlining of visual inspections

The HACARUS Check Series is an AI solution that combines HACARUS’s unique AI technology with hardware. It enables automation of visual inspections that were previously impossible, including 360-degree inspections, and its highly adaptive configuration allows for use case specific implementations. HACARUS’ strength lies in providing the most suitable AI for your operational environment and offering one-stop AI solutions customized to your business needs – enabled by best-in-class technology.


Date and time: October 11th (Wednesday) 16:30-16:40
Location: healthTECH Stage
Speaker: Nozomi Takino, Head of Platform Divison
Title: Introducing HACARUS AI platform that analyzes all kinds of data, from drug discovery to biotechnology, manufacturing, SaMD, clinical trials, and healthcare.
Content: We will introduce usage examples of the HACARUS AI platforms “HACARUS MD” and “HACARUS DD” that can hybridize both sparse models and deep learning models, as well as future developments with a view to global expansion.

Date and time: October 12th (Thursday) 15:20-15:30
Location: healthTECH Stage
Speaker: Yuki Nishimura, Medical Group
Title: Making cervical cancer screening more familiar ~ Introducing the AI software for colposcopy “HACARUS MD for Colposcopy” ~
Content: The incidence of cervical cancer continues to increase. At HACARUS, we are making full use of AI technology to make cervical cancer testing more accessible. In this presentation, we will introduce HACARUS MD for Colposcopy, an AI software for colposcopy examinations.


HACARUS INC., on a mission to bring the next generation of instruments to every industry, has since its founding in 2014, supplied solutions in 100+ AI projects across the medical, manufacturing and construction fields. Headquartered in Kyoto, Japan, and backed by Daikin, Osaka Gas and Miyako Capital (Kyoto University), among others, its technology enables humans to make better, faster, and more reliable decisions based on data-driven insights. HACARUS’ proprietary AI engine is built using Sparse Modeling, a method that understands data like a human would – by its unique key features and is far more resource, time, and energy-efficient when compared to Deep Learning. To learn more, visit https://hacarus.com

Subscribe to our newsletter

Click here to sign up